Symbolic Regression Model To Predict Choledocholithiasis
(SymChole)
1 other identifier
observational
200
1 country
1
Brief Summary
Choledocholithiasis refers to the presence of gallstones within the common bile duct. It is proposed to look for markers that help in the diagnosis and in differentiating between retained and migrated gallstones. The selection of patients is a very important aspect, due to the economic aspects and possible complications. Taking advantage of the development of technology, the improvement in computer systems, the use of artificial intelligence and a symbolic regression model that works to predict the presence of choledocholithiasis and provide evidence that clarifies the treatment of patients with this pathology, especially in this group where there is a bigger controversy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 7, 2019
CompletedFirst Submitted
Initial submission to the registry
January 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2020
CompletedFirst Posted
Study publicly available on registry
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2020
CompletedJune 1, 2020
May 1, 2020
12 months
January 20, 2020
May 29, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
To validate prospectively a symbolic regression model to predict choledocholithiasis
To validate a model to predict choledocholithiasis compared clinical predictors.
72 horas
Study Arms (1)
All patient with suspicion of choledocholithiasis
Patient with the suspect of common biliary duct stone for pain type colic in the right upper quadrant abdomen, the elevation of bilirubin, alkaline phosphatase, pancreatitis, dilated common bile duct and cholangitis. According to the criteria to assign the risk of choledocholithiasis. We are going to validate a scale based on intelligence artificial compared to the clinical predictor.
Interventions
To determine the diagnostic of Choledocholithiasis with symbolic regression model
Eligibility Criteria
Patients with clinical suspicion of choledocholithiasis.
You may qualify if:
- Patients above 18 with clinical suspicion of choledocholithiasis by biliary-type pain, laboratory testing that reveals a cholestatic pattern of liver test abnormalities, biliary pancreatitis or dilated common bile duct
You may not qualify if:
- Patient with a history of cholecystectomy
- History of previous ERCP or surgery involving bile duct
- Patient who could not be followed
- Patient with other pathology that causes alteration of liver function test.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario Dr. Jose E. Gonzalez, Universidad Autónoma de Nuevo León
Monterrey, Nuevo León, 64460, Mexico
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
José A. González González, MD
José Eleuterio González University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
January 20, 2020
First Posted
June 1, 2020
Study Start
June 7, 2019
Primary Completion
May 30, 2020
Study Completion
July 31, 2020
Last Updated
June 1, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share